Patents by Inventor Thilo Winzer
Thilo Winzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240240194Abstract: The disclosure relates to transcription cassettes and vectors comprising a nucleotide sequence encoding a transcription factor; plants, plant cells, plant cell cultures and seeds that are genetically engineered to include a recombinant copy or copies of the nucleic acid encoding said transcription factor; and processes for the extraction of benzylisoquinoline alkaloids from the genetically engineered plants.Type: ApplicationFiled: May 24, 2022Publication date: July 18, 2024Applicant: Sun Pharmaceutical Industries Australia Pty LimitedInventors: Ian Graham, Thilo Winzer
-
Patent number: 10400222Abstract: The disclosure relates to delta (12) and delta (15) desaturases and their use in the modification of oil content in hemp.Type: GrantFiled: December 8, 2014Date of Patent: September 3, 2019Assignee: The University of YorkInventors: Monika Bielecka, Filip Kaminski, Thilo Winzer, Ian Graham
-
Patent number: 10006010Abstract: This disclosure relates to the isolation of a nucleic acid molecule[s] that encode a novel cytochrome P450 and an oxidoreductase from a Papaver somniferum [P. somniferum] cultivar, transgenic cells transformed with said nucleic acid molecule and sequence variants thereof; and including methods for the production of intermediates in the production of morphinans.Type: GrantFiled: May 15, 2015Date of Patent: June 26, 2018Assignees: The University of York, Sun Pharmaceutical Industries (Australia) Pty LtdInventors: Thilo Winzer, Ian Graham, Tracy Carol Walker
-
Patent number: 9862979Abstract: The disclosure relates to a nucleic acid molecule isolated from a Papaver somniferum cultivar that produces the opiate alkaloid noscapine which comprises 10 genes involved in the biosynthesis of opiate alkaloids.Type: GrantFiled: June 15, 2016Date of Patent: January 9, 2018Assignee: Sun Pharmaceutical Industries (Australia) Pty LtdInventors: Thilo Winzer, Ian Alexander Graham, Tracy Carol Walker
-
Patent number: 9725732Abstract: This disclosure relates to the isolation and sequencing of nucleic acid molecules that encode cytochrome P450 polypeptides from a Papaver somniferum cultivar; uses in the production of noscapine and identification of poppy cultivars that include genes that comprise said nucleic acid molecules.Type: GrantFiled: October 15, 2015Date of Patent: August 8, 2017Assignee: Sun Pharmaceutical Industries (Australia) Pty LtdInventors: Thilo Winzer, Tracy Carol Walker, Ian Alexander Graham
-
Publication number: 20170058267Abstract: This disclosure relates to the isolation of a nucleic acid molecule[s] that encode a novel cytochrome P450 and an oxidoreductase from a Papaver somniferum [P. somniferum] cultivar, transgenic cells transformed with said nucleic acid molecule and sequence variants thereof; and including methods for the production of intermediates in the production of morphinans.Type: ApplicationFiled: May 15, 2015Publication date: March 2, 2017Applicants: The University of York, Sun Pharmaceutical Industries (Australia) Pty LtdInventors: Thilo Winzer, Ian Graham, Tracy Carol Walker
-
Publication number: 20160333324Abstract: The disclosure relates to delta (12) and delta (15) desaturases and their use in the modification of oil content in hemp.Type: ApplicationFiled: December 8, 2014Publication date: November 17, 2016Applicant: The University of YorkInventors: Monika Bielecka, Filip Kaminski, Thilo Winzer, Ian Graham
-
Publication number: 20160281121Abstract: The disclosure relates to a nucleic acid molecule isolated from a Papaver somniferum cultivar that produces the opiate alkaloid noscapine which comprises 10 genes involved in the biosynthesis of opiate alkaloids.Type: ApplicationFiled: June 15, 2016Publication date: September 29, 2016Applicant: Sun Pharmaceutical Industries (Australia) Pty LtdInventors: Thilo Winzer, Ian Alexander Graham, Tracy Carol Walker
-
Patent number: 9447444Abstract: The disclosure relates to a nucleic acid molecule isolated from a Papaver somniferum cultivar that produces the opiate alkaloid noscapine which comprises 10 genes involved in the biosynthesis of opiate alkaloids.Type: GrantFiled: March 12, 2013Date of Patent: September 20, 2016Assignee: Sun Pharmaceutical Industries (Australia) Pty LtdInventors: Thilo Winzer, Ian Alexander Graham, Tracy Carol Walker
-
Publication number: 20160032305Abstract: This disclosure relates to the isolation and sequencing of nucleic acid molecules that encode cytochrome P450 polypeptides from a Papaver somniferum cultivar; uses in the production of noscapine and identification of poppy cultivars that include genes that comprise said nucleic acid molecules.Type: ApplicationFiled: October 15, 2015Publication date: February 4, 2016Applicant: Sun Pharmaceutical Industries (Australia) Pty LtdInventors: Thilo Winzer, Tracy Carol Walker, Ian Alexander Graham
-
Patent number: 9200261Abstract: This disclosure relates to the isolation and sequencing of nucleic acid molecules that encode cytochrome P450 polypeptides from a Papaver somniferum cultivar; uses in the production of noscapine and identification of poppy cultivars that include genes that comprise said nucleic acid molecules.Type: GrantFiled: July 18, 2011Date of Patent: December 1, 2015Assignee: GlaxoSmithKline Australia Pty LimitedInventors: Thilo Winzer, Tracy Carol Walker, Ian Alexander Graham
-
Publication number: 20150004659Abstract: The disclosure relates to a nucleic acid molecule isolated from a Papaver somniferum cultivar that produces the opiate alkaloid noscapine which comprises 10 genes involved in the biosynthesis of opiate alkaloids.Type: ApplicationFiled: March 12, 2013Publication date: January 1, 2015Applicant: GlaxoSmithKline Australia Pty LimitedInventors: Thilo Winzer, Ian Alexander Graham, Tracy Carol Walker
-
Publication number: 20130133105Abstract: This disclosure relates to the isolation and sequencing of nucleic acid molecules that encode cytochrome P450 polypeptides from a Papaver somniferum cultivar; uses in the production of noscapine and identification of poppy cultivars that include genes that comprise said nucleic acid molecules.Type: ApplicationFiled: July 18, 2011Publication date: May 23, 2013Applicant: GlaxoSmithKline Australia Pty LimitedInventors: Thilo Winzer, Tracy Carol Walker, Ian Alexander Graham
